Shopping Cart
Remove All
Your shopping cart is currently empty
Ifabotuzumab (KB-004) is an antibody targeting EphA3+ cells, significantly reducing CCR10+ cells and improving pulmonary fibrosis in humanized NSG mice.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | In Stock | In Stock | |
| 5 mg | $810 | In Stock | In Stock | |
| 10 mg | $1,232 | - | In Stock | |
| 25 mg | $2,465 | - | In Stock |
| Description | Ifabotuzumab (KB-004) is an antibody targeting EphA3+ cells, significantly reducing CCR10+ cells and improving pulmonary fibrosis in humanized NSG mice. |
| In vivo | Ifabotuzumab's targeted killing of EphA3 + cells significantly reduced the number of CCR10 + cells and improved pulmonary fibrosis in humanized NSG mice. |
| Synonyms | KB-004, KB004, Anti-EphA3 MAb |
| Cas No. | 2147698-66-4 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.